Live Breaking News & Updates on Gregg Gilbert Truist|Page 2

Stay updated with breaking news from Gregg gilbert truist. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Eli Lilly and Company (LLY) Q1 2021 Earnings Call Transcript


Eli Lilly and Company (LLY) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Eli Lilly and Company (NYSE: LLY)
Popular Searches
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q1 2021 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the conference over to our host, Mr. Kevin Hern. Please go ahead.SPONSORED:
10 stocks we like better than Eli Lilly and Company
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

United States , White House , District Of Columbia , Mike Mason , Dave Ricks , Andrew Baum , Ilya Yuffa , Eli Lilly , Terence Flynn Goldman Sachs , Danielm Skovronsky , Aarti Shah , Louise Chen Cantor Fitzgerald , Terence Flynn , Steve Scala Cowen , Kerry Holford , Geoff Meacham , Carter Gould Barclays , Seamus Fernandez Guggenheim , Myles Oneill , Gregg Gilbert , Louise Chen , Edgardo Hernandez , Diogo Rau , Tim Anderson , Michaelb Mason , Kerry Holford Berenberg ,

Biodelivery Sciences International Inc (BDSI) Q4 2020 Earnings Call Transcript


Operator
Greetings, and welcome to the BioDelivery Sciences Fourth Quarter and Full Year 2020 Earnings Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions]
It is now my pleasure to introduce your host, Ms. Terry Coelho, Executive Vice President and Chief Financial Officer. Thank you. Please go ahead.
Terry Coelho
Executive Vice President and Chief Financial Officer
Thank you, and good morning, everyone. Welcome to our fourth quarter 2020 earnings conference call. Leading the call today is Jeff Bailey, Chief Executive Officer. We are joined by Scott Plesha, President and Chief Commercial Officer. Following our prepared remarks, we will conduct a question-and-answer session. Earlier today BioDelivery Sciences issued a press release announcing its financial results for the fourth quarter and full year 2020. A copy of the release can be found on the Investor Relations page of the comp ....

United States , Terry Coelho , Brandon Folkes Cantor Fitzgerald , Tim Chiang Northland , Tim Chiang , Jeff Bailey , Tim Lugo William Blair , Scott Plesha , Piper Sandler , Gregg Gilbert , Tim Lugo , Scott Henry , David Amsellem , Jeffreya Bailey , David Amsellem Piper Sandler , Gregg Gilbert Truist , Brandon Folkes , William Blair , Biodelivery Sciences , Biodelivery Sciences Fourth Quarter , Cantor Fitzgerald , Biodelivery Sciences International Inc , Full Year , Executive Vice President , Chief Financial , Vice President ,

Amneal Pharmaceuticals, Inc. (AMRX) Q4 2020 Earnings Call Transcript


Amneal Pharmaceuticals, Inc. (AMRX) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Amneal Pharmaceuticals, Inc. (NYSE: AMRX)
Popular Searches
Operator
Good morning and welcome to the Amneal Pharmaceuticals Fourth Quarter and Full Year 2020 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Tasos Konidaris, Executive Vice President and Chief Financial Officer. Please go ahead.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and rea ....

United States , New Jersey , Dana Flanders Guggenheim , Raymond James , Gary Nachman , Balaji Prasad Barclays , Fosun Pharma , Randy Boyer , Balaji Prasad , Mylan Xulane , Season Lee , Elliot Wilbur Raymond James , Piper Sandler , Joe Todisco , Tasos Konidaris , Gregg Gilbert , Steve Manzano , Dana Flanders , David Amsellem , David Amsellem Piper Sandler , Gregg Gilbert Truist , Chintu Patel , Elliot Wilbur , Motley Fool Amneal Pharmaceuticals Inc , Chintu Patel Co , Amneal Pharmaceuticals Fourth Quarter ,

Repros Therapeutics (RPRX) Q4 2020 Earnings Call Transcript


Repros Therapeutics (RPRX) Q4 2020 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Repros Therapeutics (NASDAQ: RPRX)
Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma fourth-quarter 2020 financial results conference call. I would now like to turn the call over to George Grofik, senior vice president, head of investor relations and communications. Please go ahead, sir.
George Grofik
Senior Vice President, Head of Investor Relations and Communications.
Thank you, operator, and good morning and good afternoon to everyone on the call. Thank you for joining us to review Royalty Pharma s fourth-quarter results. You can find the slides of this call on the investors page of our website at royaltypharma.com. Moving to Slide 3. ....

David Risinger , Terence Flynn Goldman Sachs , Jim Reddoch , Terry Coyne , Pablo Legorreta , Terence Flynn , Geoff Meacham , Steve Scala Cowen , Steve Scala , America Merrill Lynch , Mike Difiore , George Grofik , Gregg Gilbert , Mike Difiore Evercore , David Risinger Morgan Stanley , Chris Schott , Gregg Gilbert Truist , Marshall Urist , Morgan Stanley , Head Of Research , Goldman Sachs , Geoff Meacham Bank , Company Analyst , Repros Therapeutics , Motley Fool Repros Therapeutics , Call Transcript ,